1 Peppard, P. E. et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177, 1006-1014, doi:10.1093/aje/kws342 (2013).
2 Young, T. et al. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ 108, 246-249 (2009).
3 Dempsey, J. A., Veasey, S. C., Morgan, B. J. & O'Donnell, C. P. Pathophysiology of sleep apnea. Physiol Rev 90, 47-112, doi:10.1152/physrev.00043.2008 (2010).
4 Lavie, P. & Hoffstein, V. Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 24, 721-725, doi:10.1093/sleep/24.6.721 (2001).
5 Jehan, S. et al. Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease. Sleep Med Disord 4, 67-76 (2020).
6 May, A. M. & Mehra, R. Obstructive sleep apnea: role of intermittent hypoxia and inflammation. Semin Respir Crit Care Med 35, 531-544, doi:10.1055/s-0034-1390023 (2014).
7 Ganjali, S. et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233, 9237-9246, doi:10.1002/jcp.27028 (2018).
8 Atan, D., Kundi, F. C. S., Özcan, K. M. & Dere, H. A New Predictor for Obstructive Sleep Apnea Syndrome: Monocyte to HDL Ratio. Indian J Otolaryngol Head Neck Surg 69, 142-146, doi:10.1007/s12070-016-0980-6 (2017).
9 Inonu Koseoglu, H., Pazarli, A. C., Kanbay, A. & Demir, O. Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study. Clin Appl Thromb Hemost 24, 139-144, doi:10.1177/1076029616677803 (2018).
10 Li, N. et al. Relationship between monocyte to HDL cholesterol ratio and concomitant cardiovascular disease in Chinese Han patients with obstructive sleep apnea. Cardiovasc Diagn Ther 9, 362-370, doi:10.21037/cdt.2019.08.02 (2019).
11 Drager, L. F. et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 105, 1135-1139, doi:10.1016/j.amjcard.2009.12.017 (2010).
12 Kang, H. H., Kim, S. W. & Lee, S. H. Association between triglyceride glucose index and obstructive sleep apnea risk in Korean adults: a cross-sectional cohort study. Lipids Health Dis 19, 182, doi:10.1186/s12944-020-01358-9 (2020).
13 Alvarez-Martins, I. et al. The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment. Pflugers Arch 468, 919-932, doi:10.1007/s00424-016-1797-6 (2016).
14 Tamaki, S. et al. Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome. Respirology 14, 689-694, doi:10.1111/j.1440-1843.2009.01540.x (2009).
15 Barter, P. J. et al. Antiinflammatory properties of HDL. Circ Res 95, 764-772, doi:10.1161/01.RES.0000146094.59640.13 (2004).
16 Murphy, A. J. et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28, 2071-2077, doi:10.1161/ATVBAHA.108.168690 (2008).
17 Gunduz, C. et al. Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database. Respirology 23, 1180-1189, doi:10.1111/resp.13372 (2018).
18 Cetin, E. H. et al. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med 9, 967-977, doi:10.2217/bmm.15.74 (2015).
19 Balta, S. et al. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction. Am J Emerg Med 34, 1542-1547, doi:10.1016/j.ajem.2016.05.031 (2016).
20 Sag, S. et al. Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI. Clin Chem Lab Med 55, 132-138, doi:10.1515/cclm-2016-0005 (2017).
21 Karataş, M. B. et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med 34, 240-244, doi:10.1016/j.ajem.2015.10.049 (2016).
22 Selcuk, M., Yildirim, E. & Saylik, F. Comparison of monocyte with high density lipoprotein cholesterol ratio in dipper and nondipper hypertensive patients. Biomark Med 13, 1289-1296, doi:10.2217/bmm-2019-0062 (2019).
23 Aydin, E., Ates, I., Fettah Arikan, M., Yilmaz, N. & Dede, F. The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension. Hypertens Res 40, 758-764, doi:10.1038/hr.2017.36 (2017).
24 Chen, S. A. et al. The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation. BMC Cardiovasc Disord 20, 401, doi:10.1186/s12872-020-01670-3 (2020).
25 Santos-Silva, R. et al. Validation of a portable monitoring system for the diagnosis of obstructive sleep apnea syndrome. Sleep 32, 629-636, doi:10.1093/sleep/32.5.629 (2009).
26 Chernyshev, O. Y. et al. A pilot study: portable out-of-center sleep testing as an early sleep apnea screening tool in acute ischemic stroke. Nat Sci Sleep 7, 127-138, doi:10.2147/nss.S85780 (2015).
27 Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22, 667-689 (1999).